First Pacific Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.3K Sell
168
-77
-31% -$10.1K ﹤0.01% 316
2026
Q1
$34.1K Buy
245
+89
+57% +$12.5K ﹤0.01% 274
2025
Q4
$19.2K Buy
156
+6
+4% +$729 ﹤0.01% 294
2025
Q3
$16.6K Buy
150
+9
+6% +$1.02K ﹤0.01% 296
2025
Q2
$15.6K Sell
141
-4
-3% -$426 ﹤0.01% 298
2025
Q1
$16.2K Buy
+145
New +$15K ﹤0.01% 267

Other funds holding GILD

First Pacific Financial's GILD Position: Q2 2026 in Review

First Pacific Financial reduced its Gilead Sciences (GILD) stake by 31% in Q2 2026, selling an estimated $10.1K and leaving 168 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #316.

First Pacific Financial first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $34.1K in Q1 2026. 837 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • First Pacific Financial held 168 shares of Gilead Sciences worth $21.3K as of Q2 2026.
  • First Pacific Financial sold 77 Gilead Sciences shares in Q2 2026, an estimated $10.1K.
  • Gilead Sciences made up ﹤0.01% of First Pacific Financial's portfolio in Q2 2026, its #316 holding.
  • First Pacific Financial first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • First Pacific Financial's Gilead Sciences position peaked at $34.1K in Q1 2026.
  • 837 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on First Pacific Financial's 13F filing for Q2 2026, filed 20 Jul 2026.